3628 results for «280»

Filter By

3628 results

LAA closure

09 Feb 2025 – From PCR Tokyo Valves 2025

This session offers valuable insights into various aspects of left atrial appendage (LAA) closure, a critical procedure for stroke prevention in atrial fibrillation patients. Explore improvements to the safety checklist, case studies on left atrial thrombosis and mobile thrombus management, as well as a successful case...

LAA closure

Coronary access after TAVI: timing and techniques

09 Feb 2025 – From PCR Tokyo Valves 2025

Struggling with PCI after TAVI? This session breaks it down with 3 real-world cases. You'll learn when and how to perform revascularization in severe AS patients, the impact of commissure alignment on future coronary access, and expert techniques for post-TAVI PCI:

  • Case 1: Managing a patient with...
Coronary access after TAVI: timing and techniques

Expanding indications for TAVI - moderate aortic stenosis and heart failure

09 Feb 2025 – From PCR Tokyo Valves 2025

Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.

You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...

Expanding indications for TAVI - moderate aortic stenosis and heart failure

TAVI burning issues

09 Feb 2025 – From PCR Tokyo Valves 2025

This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...

TAVI burning issues

Coronary sinus reducer for microvascular angina

28 Feb 2020

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

Coronary sinus reducer for microvascular angina

A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial

25 Oct 2025

Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
VICTORY: Intravascular lithotripsy vs. super-high-pressure PTCA in calcified and refractory coronary lesions

The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction

18 Nov 2024

Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
CLEAR SYNERGY

The impact of COVID-19 pandemic on interventional cardiologists in training

23 Oct 2020

In collaboration with EuroIntervention Journal

The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...

The impact of COVID-19 pandemic on interventional cardiologists in training
Didn’t find what you were looking for?